Drug Delivery Devices Market by Route of Administration, Application, End-User and Region - Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2034
Overview
The Drug Delivery Devices Market size was valued at USD 300.62 Billion in 2025 and the total Drug Delivery Devices revenue is expected to grow at a CAGR of 7.4% from 2026 to 2034, reaching nearly USD 571.55 Billion.
Drug Delivery Devices Market Overview:
Global Drug delivery devices are specialised instruments designed to administer a drug or therapeutic material through a particular route. The medical treatments involve using the gadgets once or more than once. In many facets of product development, from regulatory strategy to design and material concerns to developing and using testing procedures, drug delivery devices pose special obstacles. Drug delivery is a vital component in administering pharmacological substances that provide therapeutic effects in people or animals. The usage of drug delivery systems among patients and clinicians is being driven by an increase in the number of diabetic patients as well as an increase in the incidence of cancer and respiratory disorders.
Drug Delivery Devices Market Size, Growth and Share Analysis
To Know About The Research Methodology :- Request Free Sample Report
In this report, the Drug Delivery Devices market's growth reasons, as well as the market's many segments (Route of Administration, Application, End-User, and Region.), are discussed. Data has been given by market players, regions, and specific requirements. This market report includes a comprehensive overview of all the significant improvements that are presently prevailing in all market segments. Key data analysis is presented in the form of statistics, infographics, and presentations. The study discusses the Drug Delivery Devices market's Drivers, Restraints, Opportunities, and Challenges. The report helps to assess the market growth drivers and determines how to use these drivers as a tool. The report also helps to rectify and resolve issues related to the Global Drug Delivery Devices market situation.
Drug Delivery Devices Market Dynamics:
In response to the rising demand, numerous businesses are creating patient-friendly drug delivery systems, and other market participants are acquiring these businesses to diversify their holdings. Prefilled syringes and auto-injectors are two examples of the patient-centric enhanced medication delivery training devices Noble International created. Through the use of sophisticated drug delivery systems, this acquisition will assist patients in appropriately administering prescriptions.
Companies in the industry are always concentrating on methods like teamwork and the creation and introduction of new items. These tactics aid the businesses in generating more money, which fuels the growth of the market as a whole. New product introductions with improved safety and user-friendly features are anticipated to draw attention from the main pharmaceutical business. Additionally, improved dosage characteristics support the results of drug therapy and raise the possibility of illness management in homecare settings.
For instance, Ypsomed introduced Ypso Mate in November 2022, claiming it to be the first auto-injector for prefilled syringes with integrated connectivity in the globe. It is available for self-administration. Additionally, there has been an increase in market participants working with pharmaceutical corporations to create and promote products.
For instance, in April 2022, KINDEVA DRUG DELIVERY collaborated with Cambridge Healthcare Innovations Limited (CHI) to develop and commercialize CHI's aeolus dry-powder inhaler (DPI) platform technology.
The top causes of death worldwide in recent years have been chronic illnesses like diabetes, cancer, asthma, and Chronic Obstructive Pulmonary Disease (COPD), among others. During the projected period, the market is expected to be driven by factors including the rising prevalence of chronic diseases like diabetes, COPD, and asthma as well as new technologies for treating these conditions. The prevalence of chronic diseases among such a sizable segment of the older population is expected to promote the uptake of such systems.Moreover, the increase in the launch of new products and digitalization in the healthcare sector has generated growth opportunities for the companies.
The U.S. FDA's tight restrictions and criteria for approving medicine delivery devices as well as product recalls are the main reasons limiting the market. A Drugwatch report from 2022 states that approximately 4,500 medications and equipment are typically recalled from U.S. shelves each year. The market growth is being constrained by frequent product recalls due to negative side effects, non-compliance, and data security issues.
For example, in 2019 Smiths Medical ASD, Inc. was forced to start a Class I regulatory recall of its ASD Medfusion 4000 Syringe Pump due to a software functionality issue that results in the device's low battery concerns. Products using cutting-edge technology must pass several governmental approval procedures.
During the forecast period, the launch of technologically advanced and novel items is anticipated to be constrained by the regulatory authorities' strict rules for evaluating the performance and safety of the products. Customers' faith in the gadget may be impacted by the devices' intrusive character, and the market's growth is being constrained by tight rules for product approval.
Drug Delivery Devices Market Segment Analysis:
By Route of Administration, During the forecast period, 2026-2034, the inhalation is expected to grow at a significant CAGR. The increasing use of inhalers and the prevalence of respiratory diseases like asthma and other bronchial problems are both factors in the growth of the inhalation market. In addition, the market growth is anticipated to be fueled by the leading players' increased product launches of inhalation systems through the forecast period.
Injectables held the largest market share in 2025 and are expected to increase at the fastest rate over the forecast period. It is anticipated that there will be more product introductions as a result of the growing demand for wearable injectable medication delivery systems, which will promote segmental growth. In addition, it is anticipated that in the near future the global vaccination campaign, which is driving up syringe demand, would help to segment growth.
For instance, Becton, Dickinson, and Company (BD) said in 2025 that it had received 2 billion injection devices altogether in pandemic orders for needles and syringes to support global COVID-19 immunisation efforts. The segmental growth is anticipated to increase due to the increased demand for syringes and needles till the vaccines are finished.
Drug Delivery Devices Market Regional Insights:
With a 34 % market share in 2025, North America region is expected to maintain its dominance through the forecast period. One of the contributing factors is the U.S. government's COVID19 immunisation drive's rapid expansion, which raised demand for syringes. In addition, a significant increase in the region's hospital admissions is anticipated to fuel the market growth for drug delivery devices in North America. The need for medicine delivery devices in the area is anticipated to rise as a result of these hospitalizations. Increased demand for advanced drug delivery delivers such as metered-dose inhalers and sensor-embedded devices and the growing incidence of chronic diseases are the other factors likely to drive the market growth in the region.
Europe is expected to have the second-largest market share in 2025 and to experience rapid growth over the course of the forecast period. The expansion is brought on by the region's increasing use of innovative products and increased knowledge of modern drug delivery methods. Additionally, it is anticipated that the introduction of new products by the major players and clinical studies for important regulatory approvals of new products will fuel market growth in the area.
For instance, in April 2022, Medtronic unveiled their prolonged infusion set, an insulin administration system that may be worn for up to seven days in a few European nations.
The objective of the report is to present a comprehensive analysis of the Drug Delivery Devices market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Drug Delivery Devices market dynamics, and structure by analyzing the market segments and projecting the Drug Delivery Devices market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Drug Delivery Devices market make the report investor’s guide.
Drug Delivery Devices Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 06 January 2026 | Enable Injections | Enable Injections secured a $30 million strategic investment from Sanofi to expand production capabilities for its enFuse wearable on-body delivery system. | The funding accelerates commercial high-volume manufacturing and broadens subcutaneous delivery options for complex biologic therapies. |
| 08 April 2026 | Aptar Digital Health | Aptar Digital Health partnered with Enable Injections as the preferred partner to develop a companion digital health solution for the enFuse on-body delivery system. | The collaboration improves patient adherence through real-time guidance, treatment recording, and analytics for large-volume biologic self-administration. |
| 22 May 2026 | Sobi | Sobi and Enable Injections received EU MDR CE Mark certification for the ASPAVELI enFuse on-body drug delivery system to administer subcutaneous pegcetacoplan in Europe. | The approval transitions rare disease treatments from intravenous infusions to hands-free, home-based subcutaneous self-administration for patients aged 12 and older. |
| 01 July 2026 | West Pharmaceutical Services | West Pharmaceutical Services completed the transaction to sell and transfer manufacturing rights for its SmartDose 3.5mL On-Body Delivery System. | The strategic divesting allows the company to reallocate operational focus toward scaling its 10mL large-volume adaptive delivery technologies. |
| 06 August 2026 | RenovoRx | RenovoRx initiated the first commercial clinical application of its FDA-cleared RenovoCath drug-delivery device for localized chemotherapy in a sarcoma patient. | This clinical achievement expands targeted micro-perfusion delivery beyond pancreatic cancer to treat diverse solid tumors with reduced systemic toxicity. |
Drug Delivery Devices Market Scope: Inquire before buying
| Drug Delivery Devices Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 300.62 Billion |
| Forecast Period 2026 to 2034 CAGR: | 7.4 % | Market Size in 2034: | USD 571.55 Billion |
| Segments Covered: | by Route of Administration | Oral Inhalation Transdermal Injectable Others |
|
| by Application | Oncology Infectious Diseases Respiratory Diseases Diabetes Cardiovascular Diseases Autoimmune Diseases Central Nervous System Disorders Others |
||
| by End-User | Hospitals Diagnostic Centers Ambulatory Surgery Centers/Clinics Home Care Settings Others |
||
Drug Delivery Devices Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)
Drug Delivery Devices Market Key Players are:
The Drug Delivery Devices includes the global economic activity, revenue, and manufacturing of specialized medical equipment and hardware designed to introduce therapeutic pharmaceutical substances into the human body safely, precisely, and in a controlled manner. This market strictly measures spending on the administration tools themselves such as inhalers, auto-injectors, infusion pumps, and transdermal patchesrather than the chemical drugs they carry.
| Company Name | Headquarters | Core Competencies |
| BD | Franklin Lakes, New Jersey, USA | Prefillable syringes, injection systems, drug delivery devices, and pharmaceutical packaging |
| F. Hoffmann-La Roche Ltd | Basel, Switzerland | Drug delivery systems, autoinjectors, diabetes care, and biologics |
| Halozyme Therapeutics | San Diego, California, USA | ENHANZE® drug delivery technology, subcutaneous delivery platforms, and biologics |
| Novartis AG | Basel, Switzerland | Innovative drug delivery systems, ophthalmic delivery, and biologics |
| 3M | Saint Paul, Minnesota, USA | Transdermal drug delivery systems, inhalation technologies, and medical adhesives |
| Sulzer Ltd | Winterthur, Switzerland | Drug delivery components, mixing technologies, and medical manufacturing solutions |
| Gerresheimer AG | Düsseldorf, Germany | Drug containment systems, syringes, pens, inhalers, and injectable solutions |
| Sanofi | Paris, France | Insulin pens, autoinjectors, biologics, and specialty drug delivery |
| Johnson & Johnson | New Brunswick, New Jersey, USA | Injectable therapies, medical devices, and advanced drug delivery |
| Bayer AG | Leverkusen, Germany | Drug-device combinations, women's health, and radiology delivery systems |
| GSK plc | London, United Kingdom | Respiratory inhalers, vaccine delivery, and specialty pharmaceuticals |
| Novosanis | Wijnegem, Belgium | Non-invasive drug and sample collection devices |
| medmix AG | Baar, Switzerland | Precision drug delivery devices, dispensers, and injection systems |
| Merck & Co., Inc. | Rahway, New Jersey, USA | Vaccines, biologics, and advanced injectable drug delivery |
| Pfizer Inc. | New York, New York, USA | Injectable medicines, biologics, and combination drug-device products |
| Insulet Corporation | Acton, Massachusetts, USA | Wearable insulin delivery systems and tubeless insulin pumps |
| West Pharmaceutical Services, Inc. | Exton, Pennsylvania, USA | Injectable packaging, containment systems, self-injection devices, and delivery components |
| SMC Ltd. | Somerset, Wisconsin, USA | Disposable drug delivery devices, autoinjectors, and wearable injectors |
| Ypsomed AG | Burgdorf, Switzerland | Pen injectors, autoinjectors, wearable injectors, and diabetes delivery systems |
| SHL Medical AG | Zug, Switzerland | Autoinjectors, wearable drug delivery devices, and biologics delivery platforms |
Frequently Asked Questions:
1. What was the Global Drug Delivery Devices Market size in 2025?
Ans: The Global Drug Delivery Devices Market size was USD 300.62 Billion in 2025.
2. What is the Forecast Period of the Drug Delivery Devices Market?
Ans. Forecast Period for Drug Delivery Devices Market in 2026-2034.
3. What is the projected market size & growth rate of the Drug Delivery Devices Market?
Ans. Drug Delivery Devices Market is expected to grow at 7.4 % through 2026 to 2034, reaching nearly USD 571.55 Billion.
4. What segments are covered in the Drug Delivery Devices Market report?
Ans. The segments covered are Route of Administration, Application, End-User, and Region.